Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 4, 2021, in connection with the IPO, Adrienne Harris, Kai Schmitz and Senator Joseph Lieberman were appointed to the board of directors of the Company (the “Board”). Effective March 4, 2021, Ms. Harris, Mr. Schmitz and Senator Lieberman were appointed to the Board’s Audit Committee and the Board’s Nominating and Corporate Governance Committee, and Ms. Harris and Senator Lieberman were appointed to the Board’s Compensation Committee, with Mr. Schmitz serving as chair of the Audit Committee, Ms. Harris serving as chair of the Nominating and Corporate Governance Committee and Senator Lieberman serving as chair of the Compensation Committee.
Following the appointment of Ms. Harris, Mr. Schmitz and Senator Lieberman, the Board is comprised of the following three classes: the term of office of the first class of directors, consisting of Kai Schmitz, will expire at the Company’s first annual general meeting. The term of office of the second class of directors, consisting of Adrienne Harris and Senator Joseph Lieberman, will expire at the Company’s second annual general meeting. The term of office of the third class of directors, consisting of John Martin and Brendan Carroll, will expire at the Company’s third annual general meeting.
On March 4, 2021, in connection with their appointments to the Board, each of the members of the Board entered into the Letter Agreement, as well as an indemnity agreement with the Company in the form previously filed as Exhibit 10.5 to the Registration Statement.
Prior to the IPO, on January 18, 2021, the Sponsor transferred 20,000 Class B ordinary shares of the Company to each of Adrienne Harris, Kai Schmitz and Senator Joseph Lieberman, each at the same per share price paid by the Sponsor (“founder shares”), resulting in the Sponsor holding 6,408,750 founder shares.
Other than the foregoing, each of Ms. Harris, Mr. Schmitz and Senator Lieberman is not party to any arrangement or understanding with any person pursuant to which she or he was appointed as director, nor is she or he party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and the form of indemnity agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and form of indemnity agreement, copies of which are attached as Exhibit 10.1 hereto and Exhibit 10.5 to the Registration Statement, respectively, and are incorporated herein by reference.
Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.
On March 4, 2021, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended and Restated Memorandum and Articles of Association”), effective the same day. The terms of the Amended and Restated Memorandum and Articles of Association are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended and Restated Memorandum and Articles of Association is attached as Exhibit 3.1 hereto and incorporated herein by reference.
Item 8.01. Other Events.
A total of $255,784,660, comprised of $250,668,966.80 of the proceeds from the IPO (which amount includes $8,952,463 of the underwriters’ deferred discount) and $5,115,693.20 of the proceeds of the sale of the Private Placement Warrants, was placed in a U.S.-based trust account at Bank of America, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes and up to $100,000 of interest to pay dissolution expenses, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Class A Ordinary Shares included in the Units sold in the IPO (the “public shares”) properly submitted in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial business combination or to redeem 100% of the public shares if it does not complete its initial business combination within 24 months from the closing of the IPO or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity or (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 24 months from the closing of the IPO, subject to applicable law.